Finerenone: Reducing Progressive Kidney Dysfunction and Secondary Cardiovascular Complications in Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

被引：0
|
作者：
Beacom, Robin E. [1 ]
Blankenship, James K. [2 ]
Harrington, Deedra H. [2 ]
机构：
[1] Univ Louisiana Lafayette, Coll Nursing & Hlth Sci, Lafayette, LA 70504 USA
[2] Univ Louisiana, Coll Nursing & Hlth Sci, Lafayette, LA USA
来源：
JNP- THE JOURNAL FOR NURSE PRACTITIONERS | 2022年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.nurpra.2022.04.009
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：800 / 801
页数：2
相关论文
共 50 条
  • [1] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2020, 142 (24) : E470 - E470
  • [2] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [3] Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    McGuire, Darren K.
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Jankowska, Ewa A.
    Michos, Erin D.
    Farmakis, Dimitrios
    Farjat, Alfredo E.
    Kolkhof, Peter
    Scalise, Andrea
    Joseph, Amer
    Bakris, George L.
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 85 - 93
  • [4] Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Anker, Stefan D.
    Filippatos, Gerasimos
    Ruilope, Luis M.
    Kovesdy, Csaba P.
    Tuttle, Katherine
    Vaduganathan, Muthiah
    Wanner, Christoph
    Bansilal, Sameer
    Gebel, Martin
    Joseph, Amer
    Lawatscheck, Robert
    Bakris, George L.
    JAMA CARDIOLOGY, 2023, 8 (08) : 732 - 741
  • [5] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [6] Finerenone in patients with chronic kidney disease and type 2 diabetes mellitus
    Wanner, C.
    Nitschmann, S.
    INTERNIST, 2021, 62 (05): : 577 - 580
  • [7] Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
    Pitt, Bertram
    Filippatos, Gerasimos
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Ruilope, Luis M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2252 - 2263
  • [8] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Moura-Neto, Jose A.
    Ronco, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [9] Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes
    Ashjian, Emily
    Clarke, Megan
    Pogue, Kristen
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (23) : 1708 - 1721
  • [10] Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease-The FIDELITY Pooled Analysis
    Humle, Karin
    Klanger, Boris
    Kolkhof, Peter
    Rosas, Sylvia E.
    Rossing, Peter
    Wright, Eugene
    Jefferson, Nichole
    DIABETES THERAPY, 2024, 15 (09) : 1861 - 1864
12345